Dkms
- Assets
- $22.3m
- Revenue
- $47.3m
- Investments
- $0.0
- Employees
- 81
- Location
- New York, NY
- Founding
- 06/2005
- Data as of
- 12/2022
- EIN
- 20-0989212
Organization Overview
Dkms, operating under the name Delete Blood Cancer, is located in New York, NY. The organization was established in 2005. According to its NTEE Classification (E65) the organization is classified as: Organ & Tissue Banks, under the broad grouping of Health Care and related organizations. As of 12/2022, Delete Blood Cancer employed 81 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Delete Blood Cancer is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Delete Blood Cancer generated $47.3m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (0.9%) each year. All expenses for the organization totaled $43.0m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (1.6%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
DKMS LEADS THE FIGHT TO DEFEAT BLOOD CANCER BY EMPOWERING PEOPLE TO TAKE ACTION, GIVE BONE MARROW AND SAVE LIVES. DKMS IS PART OF THE LARGEST BONE MARROW DONOR CENTER IN THE WORLD.
Describe the Organization's Program Activity:
Part 3 - Line 4a
TRANSPORT FACILITATION: COORDINATED THE TRANSPORTS OF 1,253 BONE MARROW OR BLOOD STEM CELLS PRODUCTS FROM GERMANY TO U.S PATIENTS. THIS PROVIDED THEM WITH A SECOND CHANCE AT LIFE. (IN 2021 - 1,416).
MARKETING TO TRANSPLANT CENTERS.
DONOR RECRUITMENT: RECRUITED 25,688 (33,258 IN 2021) VOLUNTEER BONE MARROW & BLOOD STEM CELL DONORS. THIS INCREASES THE CHANCES FOR PATIENTS DEALING WITH VARIOUS BLOOD CANCERS TO FIND A LIFE -SAVING DONOR MATCH.
REQUEST MANAGEMENT: FACILITATED 414 (353 IN 2021) COLLECTIONS OF BONE MARROW AND BLOOD STEM CELL PRODUCTS FROM UNRELATED VOLUNTEER DONORS, WHICH ARE TRANSPLANTED INTO PATIENTS, THUS PROVIDING A SECOND CHANCE AT LIFE FOR THOSE PATIENTS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Sirko Geist Treasurer | OfficerTrustee | 5 | $0 |
Katharina Harf Chairwoman Of The Board | Trustee | 5 | $0 |
Sergio Giralt Director | Trustee | 3 | $0 |
Dr Elke Neujahr Executive Vice Chairwoman | OfficerTrustee | 5 | $0 |
Dr Alexander Schmidt Secretary Of The Board | OfficerTrustee | 5 | $0 |
Jerome-Oliver Quella Treasurer | OfficerTrustee | 5 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Dkms Germany See Schedule O | 12/30/22 | $25,336,044 |
Adp Total Source Payroll And Benefits | 12/30/22 | $5,388,195 |
Ecs European Courier Services Llc See Schedule O | 12/30/22 | $2,218,480 |
Time Matters Gmbh See Schedule O | 12/30/22 | $2,174,250 |
Dkms Life Science Lab Gmbh See Schedule O | 12/30/22 | $769,704 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $5,136,170 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $634,846 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $5,771,016 |
| Total Program Service Revenue | $39,957,150 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $434,682 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $47,341,531 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $490,752 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $4,336,804 |
| Pension plan accruals and contributions | $29,212 |
| Other employee benefits | $756,449 |
| Payroll taxes | $310,995 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $321,417 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $98,645 |
| Advertising and promotion | $1,607,425 |
| Office expenses | $932,376 |
| Information technology | $1,142,033 |
| Royalties | $0 |
| Occupancy | $1,304,469 |
| Travel | $71,304 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $54,311 |
| Insurance | $132,604 |
| All other expenses | $74,793 |
| Total functional expenses | $43,048,619 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $11,765,008 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $5,573,835 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $183,376 |
| Net Land, buildings, and equipment | $627,460 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $4,177,757 |
| Total assets | $22,327,436 |
| Accounts payable and accrued expenses | $8,876,064 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $4,575,350 |
| Total liabilities | $13,451,414 |
| Net assets without donor restrictions | $8,876,022 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $22,327,436 |